Sign in

CIK 0001157601

  • Large accelerated filer

MADRIGAL PHARMACEUTICALS, INC.

Sign in to watch
Ticker
MDGL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 267-824-2827
Business address
1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
Former names
MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
  1. 4 Open-market buy Director bought 116,997 shares at an average $7.51 ($878,249)
  2. 4 Open-market buy Director bought 26,400 shares at an average $7.16 ($189,050)
  3. 4 Grant or award Sr. VP, Chief Comm. Officer acquired 25,000 shares (grant or award)
  4. 3 Insider Initial Statement of Ownership
  5. 4 Grant or award Director acquired 1,349 shares (grant or award)
  6. 4 Grant or award Director acquired 5,398 shares (grant or award)
  7. 4 Grant or award Director acquired 5,398 shares (grant or award)
  8. 4 Grant or award Director acquired 8,097 shares (grant or award)
  9. 4 Open-market buy Director bought 30,000 shares at an average $7.16 ($214,874)
  10. 4 Open-market buy Director bought 50,000 shares at an average $7.05 ($352,261)
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 5 Insider Annual Insider Trading Report

Page 26 of 29 · 564 filings